• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脓毒症研究的新方法。

New approaches to the study of sepsis.

机构信息

Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.

出版信息

EMBO Mol Med. 2012 Dec;4(12):1234-43. doi: 10.1002/emmm.201201375.

DOI:10.1002/emmm.201201375
PMID:23208733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3531600/
Abstract

Models of sepsis have been instructive in understanding the sequence of events in animals and, to an extent, in humans with sepsis. Events developing early in sepsis suggest that a hyperinflammatory state exists, accompanied by a buildup of oxidants in tissues reflective of a redox imbalance. Development of immunosuppression and degraded innate and adaptive immune responses are well-established complications of sepsis. In addition, there is robust activation of the complement system, which contributes to the harmful effects of sepsis. These events appear to be associated with development of multiorgan failure. The relevance of animal models of sepsis to human sepsis and the failure of human clinical trials are discussed, together with suggestions as to how clinical trial design might be improved.

摘要

败血症模型在理解动物和一定程度上败血症患者的事件序列方面具有启发性。败血症早期发生的事件表明存在过度炎症状态,同时组织中氧化剂的积累反映了氧化还原失衡。免疫抑制和先天及适应性免疫反应受损是败血症的既定并发症。此外,补体系统也被强烈激活,这有助于败血症的有害影响。这些事件似乎与多器官衰竭的发展有关。本文讨论了败血症动物模型与人类败血症的相关性以及人类临床试验的失败,并就如何改进临床试验设计提出了建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ec/3531600/01936d8caef7/emmm0004-1234-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ec/3531600/4422dcbb14b5/emmm0004-1234-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ec/3531600/205485d77c65/emmm0004-1234-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ec/3531600/01936d8caef7/emmm0004-1234-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ec/3531600/4422dcbb14b5/emmm0004-1234-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ec/3531600/205485d77c65/emmm0004-1234-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ec/3531600/01936d8caef7/emmm0004-1234-f3.jpg

相似文献

1
New approaches to the study of sepsis.脓毒症研究的新方法。
EMBO Mol Med. 2012 Dec;4(12):1234-43. doi: 10.1002/emmm.201201375.
2
Role of C5 activation products in sepsis.C5 激活产物在脓毒症中的作用。
ScientificWorldJournal. 2010 Dec 14;10:2395-402. doi: 10.1100/tsw.2010.216.
3
Complement as a Major Inducer of Harmful Events in Infectious Sepsis.补体作为感染性脓毒症有害事件的主要诱导剂。
Shock. 2020 Nov;54(5):595-605. doi: 10.1097/SHK.0000000000001531.
4
The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.补体、C5a及其受体在脓毒症和多器官功能障碍综合征中的作用。
J Invest Surg. 2006 Jul-Aug;19(4):255-65. doi: 10.1080/08941930600778263.
5
The harmful role of c5a on innate immunity in sepsis.C5a 在脓毒症固有免疫中的有害作用。
J Innate Immun. 2010;2(5):439-45. doi: 10.1159/000317194. Epub 2010 Jun 26.
6
Immunosuppression in patients who die of sepsis and multiple organ failure.死于脓毒症和多器官衰竭的患者的免疫抑制。
JAMA. 2011 Dec 21;306(23):2594-605. doi: 10.1001/jama.2011.1829.
7
Role of complement in multiorgan failure.补体在多器官功能衰竭中的作用。
Clin Dev Immunol. 2012;2012:962927. doi: 10.1155/2012/962927. Epub 2012 Dec 20.
8
[Pathophysiological basis of surgery-linked sepsis].[手术相关脓毒症的病理生理基础]
Chirurg. 2011 Mar;82(3):199-207. doi: 10.1007/s00104-010-2010-7.
9
In vivo biological responses in the presence or absence of C3.在有或没有C3的情况下的体内生物学反应。
Adv Exp Med Biol. 2007;598:240-50. doi: 10.1007/978-0-387-71767-8_17.
10
The dark side of C5a in sepsis.脓毒症中C5a的负面影响。
Nat Rev Immunol. 2004 Feb;4(2):133-42. doi: 10.1038/nri1269.

引用本文的文献

1
Transforming sepsis management: AI-driven innovations in early detection and tailored therapies.变革脓毒症管理:人工智能驱动的早期检测与个性化治疗创新
Crit Care. 2025 Aug 19;29(1):366. doi: 10.1186/s13054-025-05588-0.
2
Evaluating skeletal muscle wasting and weakness in models of critical illness.评估危重病模型中的骨骼肌消耗和虚弱情况。
Clin Sci (Lond). 2025 Jul 1;139(13):743-67. doi: 10.1042/CS20255458.
3
Endothelial CLEC5A drives barrier dysfunction and vascular leakage responsible for lung injury in bacterial pneumonia and sepsis.

本文引用的文献

1
Association between systemic corticosteroids and outcomes of intensive care unit-acquired pneumonia.全身皮质类固醇与重症监护病房获得性肺炎结局的关系。
Crit Care Med. 2012 Sep;40(9):2552-61. doi: 10.1097/CCM.0b013e318259203d.
2
The search for effective therapy for sepsis: back to the drawing board?寻找脓毒症的有效治疗方法:要从头开始吗?
JAMA. 2011 Dec 21;306(23):2614-5. doi: 10.1001/jama.2011.1853.
3
Immunosuppression in patients who die of sepsis and multiple organ failure.死于脓毒症和多器官衰竭的患者的免疫抑制。
内皮细胞CLEC5A导致屏障功能障碍和血管渗漏,这是细菌性肺炎和脓毒症中肺损伤的原因。
Sci Adv. 2025 Jun 13;11(24):eadt7589. doi: 10.1126/sciadv.adt7589. Epub 2025 Jun 11.
4
Stage-specific expression of Toll-like receptors in the seminiferous epithelium of mouse testis.睾丸生精上皮中 Toll 样受体的阶段特异性表达。
Histochem Cell Biol. 2024 Oct;162(4):323-335. doi: 10.1007/s00418-024-02310-z. Epub 2024 Jul 31.
5
Identifying biomarkers deciphering sepsis from trauma-induced sterile inflammation and trauma-induced sepsis.识别生物标志物,以区分脓毒症与创伤引起的无菌性炎症和创伤性脓毒症。
Front Immunol. 2024 Jan 12;14:1310271. doi: 10.3389/fimmu.2023.1310271. eCollection 2023.
6
Purinergic P2X7 receptor expression increases in leukocytes from intra-abdominal septic patients.嘌呤能 P2X7 受体在腹腔感染患者的白细胞中表达增加。
Front Immunol. 2023 Nov 29;14:1297249. doi: 10.3389/fimmu.2023.1297249. eCollection 2023.
7
Secreted Frizzled Related Protein 5 (SFRP5) Serum Levels Are Decreased in Critical Illness and Sepsis and Are Associated with Short-Term Mortality.重症疾病和脓毒症患者血清中分泌型卷曲相关蛋白5(SFRP5)水平降低,且与短期死亡率相关。
Biomedicines. 2023 Jan 22;11(2):313. doi: 10.3390/biomedicines11020313.
8
T cell dysregulation in inflammatory diseases in ICU.重症监护病房炎症性疾病中的T细胞失调。
Intensive Care Med Exp. 2022 Oct 24;10(1):43. doi: 10.1186/s40635-022-00471-6.
9
Glycolytic and lipid oxidative metabolic programs are essential for freshly-isolated regulatory T cells in mice with sepsis.糖酵解和脂质氧化代谢程序对于脓毒症小鼠体内新鲜分离的调节性T细胞至关重要。
RSC Adv. 2020 Jun 3;10(35):21000-21008. doi: 10.1039/d0ra01947j. eCollection 2020 May 27.
10
The benefits, limitations and opportunities of preclinical models for neonatal drug development.新生儿药物开发的临床前模型的优势、局限性和机遇。
Dis Model Mech. 2022 Apr 1;15(4). doi: 10.1242/dmm.049065. Epub 2022 Apr 25.
JAMA. 2011 Dec 21;306(23):2594-605. doi: 10.1001/jama.2011.1829.
4
Genomically humanized mice: technologies and promises.基因人源化小鼠:技术与前景。
Nat Rev Genet. 2011 Dec 16;13(1):14-20. doi: 10.1038/nrg3116.
5
Glucan-immunostimulant, adjuvant, potential drug.葡聚糖免疫刺激剂、佐剂、潜在药物。
World J Clin Oncol. 2011 Feb 10;2(2):115-9. doi: 10.5306/wjco.v2.i2.115.
6
Inhibiting the C5-C5a receptor axis.抑制 C5-C5a 受体轴。
Mol Immunol. 2011 Aug;48(14):1631-42. doi: 10.1016/j.molimm.2011.04.014. Epub 2011 May 6.
7
Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?盲肠结扎穿刺术:多微生物脓毒症的金标准模型?
Trends Microbiol. 2011 Apr;19(4):198-208. doi: 10.1016/j.tim.2011.01.001.
8
Role of endothelial chemokines and their receptors during inflammation.内皮趋化因子及其受体在炎症过程中的作用。
J Invest Surg. 2011;24(1):18-27. doi: 10.3109/08941939.2010.521232.
9
Sterile inflammation: sensing and reacting to damage.无菌性炎症:感知和应对损伤。
Nat Rev Immunol. 2010 Dec;10(12):826-37. doi: 10.1038/nri2873. Epub 2010 Nov 19.
10
The lingering consequences of sepsis: a hidden public health disaster?脓毒症的长期后果:一场隐匿的公共卫生灾难?
JAMA. 2010 Oct 27;304(16):1833-4. doi: 10.1001/jama.2010.1546.